Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

Clinical trial NCT06865105 · RECRUITING

Trial details

NCT number: NCT06865105
Sponsor: AbbVie
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2025-04-11
Primary completion: 2027-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.